Status:
COMPLETED
A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
This prospective, multicenter, observational study will evaluate the use of concomitant glucocorticoid therapy in adults with rheumatoid arthritis (RA) being treated with tocilizumab in daily clinical...
Eligibility Criteria
Inclusion
- Diagnosis of moderate to severe RA, defined as DAS28 greater than or equal to 3.7
- Naive to tocilizumab, or received tocilizumab within 8 weeks prior to enrollment
- Physician has made decision to commence IV or SC tocilizumab in accordance with label and reimbursement criteria
- Treated with glucocorticoids for RA when starting tocilizumab treatment
Exclusion
- Treatment with any investigational agent within 4 weeks or 5 half-lives before tocilizumab
- Continuous or regular treatment with oral corticosteroids for any indication other than RA
Key Trial Info
Start Date :
March 30 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 4 2019
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT03291457
Start Date
March 30 2017
End Date
December 4 2019
Last Update
May 18 2020
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
ASZ Aalst
Aalst, Belgium, 9300
2
Onze Lieve Vrouwziekenhuis Aalst
Aalst, Belgium, 9300
3
Dr. Huppertz - Marx pgmbh
Amel, Belgium, 4770
4
Private Practice Els Van Essche
Bonheiden, Belgium, 2820